Lv4
790 积分 2025-09-11 加入
DeePNAP: A Deep Learning Method to Predict Protein–Nucleic Acid Binding Affinity from Their Sequences
3小时前
已完结
Dovitinib (CHIR258, TKI258): Structure, Development and Preclinical and Clinical Activity
2个月前
已完结
Dovitinib (CHIR258, TKI258): Structure, Development and Preclinical and Clinical Activity
2个月前
已关闭
Structural basis and selectivity of sulfatinib binding to FGFR and CSF-1R
2个月前
已完结
Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment
2个月前
已完结
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
2个月前
已完结
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
2个月前
已完结
Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation
2个月前
已完结
Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting
2个月前
已完结
Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor models
2个月前
已完结
皖公网安备34019202002308
